Image via Wikipedia
NEW YORK (GenomeWeb News) – Bioinformatics company Eureka Genomics has reeled in a $750,000 Phase II Small Business Innovation Research grant from the Department of Homeland Security to continue to develop tools to detect rare variants of the anthrax pathogen Bacillus anthracis.
Houston-based Eureka is a private firm that develops next-generation sequencing analysis tools for use in discovering microorganisms associated with disease. It also provides sequencing and analysis services.
Full Story On Genome Daily News
Related articles
- Now, suitcase-sized device to detect anthrax (news.bioscholar.com)
- Future Environment Designs sponsors Bacillus anthracis and Anthrax Video (futureenv.blogspot.com)
- Nanotechnology detector for deadly anthrax (nanowerk.com)
- Will the Cloud Save Genomics? [Mike the Mad Biologist] (scienceblogs.com)
Interesting – I have no idea what it means, but it’s definitely interesting.
What this means is our broker than broke government is still finding ways to piss money away. If a company wants to develop such a product, cool. There should not be ANY public money used for helping their research efforts. And the only threat we have from anthrax is the possibility that our own government will ‘accidentally’ release it somehow.